ARQ Wealth Advisors LLC Takes Position in McKesson Corporation $MCK

Key Points

• ARQ Wealth Advisors opened a new position in McKesson, buying 5,748 shares worth about $4,445,000, while institutional investors and hedge funds now own roughly 85.07% of the stock.
• McKesson beat quarterly expectations with $9.34 EPS versus $9.19 consensus and $106.16B in revenue, set FY2026 guidance of $38.80–$39.20 EPS, and carries a consensus analyst rating of "Moderate Buy" with a target near $960.93.
• Insiders have sold 3,868 shares (~$3.74M) over the past 90 days (insider ownership ~0.08%), and the company declared a quarterly dividend of $0.82 ($3.28 annual, yield ~0.3%).

ARQ Wealth Advisors LLC bought a new stake in McKesson Corporation (NYSE:MCK - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor bought 5,748 shares of the company's stock, valued at approximately $4,445,000.

Several other hedge funds have also bought and sold shares of MCK. Brighton Jones LLC raised its stake in McKesson by 46.3% in the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company's stock valued at $1,438,000 after buying an additional 798 shares during the period. Caxton Associates LLP bought a new position in shares of McKesson during the 1st quarter worth approximately $233,000. Sivia Capital Partners LLC increased its holdings in shares of McKesson by 77.9% during the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company's stock worth $502,000 after acquiring an additional 300 shares during the last quarter. Cetera Investment Advisers increased its holdings in shares of McKesson by 0.8% during the 2nd quarter. Cetera Investment Advisers now owns 37,812 shares of the company's stock worth $27,708,000 after acquiring an additional 297 shares during the last quarter. Finally, Avantax Advisory Services Inc. raised its stake in McKesson by 7.6% in the 2nd quarter. Avantax Advisory Services Inc. now owns 4,556 shares of the company's stock valued at $3,339,000 after acquiring an additional 320 shares during the period. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at McKesson

In related news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the company's stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $955.00, for a total transaction of $313,240.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Leann B. Smith sold 190 shares of the stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the transaction, the executive vice president owned 2,989 shares in the company, valued at approximately $2,824,605. The trade was a 5.98% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 3,868 shares of company stock worth $3,743,820. 0.08% of the stock is currently owned by insiders.

McKesson Trading Down 0.1%

Shares of McKesson stock opened at $942.57 on Wednesday. McKesson Corporation has a 1 year low of $637.00 and a 1 year high of $999.00. The firm's 50 day moving average is $898.61 and its 200 day moving average is $830.00. The firm has a market capitalization of $115.45 billion, a PE ratio of 27.11, a price-to-earnings-growth ratio of 1.52 and a beta of 0.38.

McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping analysts' consensus estimates of $9.19 by $0.15. The company had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm's quarterly revenue was up 11.4% on a year-over-year basis. During the same period in the previous year, the firm earned $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, research analysts anticipate that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.3%. McKesson's dividend payout ratio is currently 9.43%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on MCK shares. JPMorgan Chase & Co. raised their price target on McKesson from $983.00 to $1,107.00 and gave the company an "overweight" rating in a report on Tuesday, February 10th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating on shares of McKesson in a research report on Wednesday, December 10th. Weiss Ratings cut shares of McKesson from a "buy (a-)" rating to a "buy (b+)" rating in a research note on Thursday, February 5th. Mizuho lifted their target price on shares of McKesson from $880.00 to $885.00 and gave the stock a "neutral" rating in a report on Thursday, February 5th. Finally, Leerink Partners reissued an "outperform" rating and issued a $1,085.00 price target on shares of McKesson in a report on Thursday, March 5th. Thirteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $960.93.

About McKesson

McKesson Corporation NYSE: MCK is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company's core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.